Market Research Logo

Europe Chronic Obstructive Pulmonary Disease Market and Competitive Landscape – 2017

Europe Chronic Obstructive Pulmonary Disease Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Chronic Obstructive Pulmonary Disease Market and Competitive Landscape – 2017, provides comprehensive insights into Chronic Obstructive Pulmonary Disease pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Chronic Obstructive Pulmonary Disease market size and drug sales. This research also provides insights into Chronic Obstructive Pulmonary Disease epidemiology and late stage pipeline.
The report is classified into nine sections – Chronic Obstructive Pulmonary Disease overview with definitions, symptoms, etiology, diagnosis, treatment options; Chronic Obstructive Pulmonary Disease pipeline insights covering late stage clinical trials pipeline; Chronic Obstructive Pulmonary Disease prevalence trends by countries; Chronic Obstructive Pulmonary Disease market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

  • Chronic Obstructive Pulmonary Disease pipeline: Find out the drugs in clinical trials for Chronic Obstructive Pulmonary Disease by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Chronic Obstructive Pulmonary Disease epidemiology: Find out the prevalence of Chronic Obstructive Pulmonary Disease by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Chronic Obstructive Pulmonary Disease products: Identify key products marketed and prescribed for Chronic Obstructive Pulmonary Disease by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Chronic Obstructive Pulmonary Disease market size: Find out the market size for Chronic Obstructive Pulmonary Disease drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Chronic Obstructive Pulmonary Disease drug sales: Find out the sales of Chronic Obstructive Pulmonary Disease drugs by countries – Europe, Germany, France, Italy, Spain, UK
  • Chronic Obstructive Pulmonary Disease drugs sales forecast: Sales forecast for Chronic Obstructive Pulmonary Disease drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Chronic Obstructive Pulmonary Disease market share analysis: Find out the market shares of Chronic Obstructive Pulmonary Disease drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Chronic Obstructive Pulmonary Disease drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Chronic Obstructive Pulmonary Disease market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Chronic Obstructive Pulmonary Disease market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Chronic Obstructive Pulmonary Disease: Disease Overview
1.1. Chronic Obstructive Pulmonary Disease Symptoms
1.2. Chronic Obstructive Pulmonary Disease Etiology
1.3. Chronic Obstructive Pulmonary Disease Diagnosis
1.4. Chronic Obstructive Pulmonary Disease Treatment Options
2. Chronic Obstructive Pulmonary Disease Pipeline Insights
2.1. Chronic Obstructive Pulmonary Disease Phase 3 Clinical Trials
2.2. Chronic Obstructive Pulmonary Disease Phase 2 Clinical Trials
2.3. Chronic Obstructive Pulmonary Disease Phase 1 Clinical Trials
3. Chronic Obstructive Pulmonary Disease Epidemiology Analysis
4. Germany Chronic Obstructive Pulmonary Disease Market Insights
4.1. Marketed Products for Chronic Obstructive Pulmonary Disease in Germany
4.2. Germany Chronic Obstructive Pulmonary Disease Market Size & Forecast
4.3. Germany Chronic Obstructive Pulmonary Disease Product Sales Forecast
4.4. Germany Chronic Obstructive Pulmonary Disease Market Share Analysis
5. France Chronic Obstructive Pulmonary Disease Market Insights
5.1. Marketed Products for Chronic Obstructive Pulmonary Disease in France
5.2. France Chronic Obstructive Pulmonary Disease Market Size & Forecast
5.3. France Chronic Obstructive Pulmonary Disease Product Sales Forecast
5.4. France Chronic Obstructive Pulmonary Disease Market Share Analysis
6. Italy Chronic Obstructive Pulmonary Disease Market Insights
6.1. Marketed Products for Chronic Obstructive Pulmonary Disease in Italy
6.2. Italy Chronic Obstructive Pulmonary Disease Market Size & Forecast
6.3. Italy Chronic Obstructive Pulmonary Disease Product Sales Forecast
6.4. Italy Chronic Obstructive Pulmonary Disease Market Share Analysis
7. Spain Chronic Obstructive Pulmonary Disease Market Insights
7.1. Marketed Products for Chronic Obstructive Pulmonary Disease in Spain
7.2. Spain Chronic Obstructive Pulmonary Disease Market Size & Forecast
7.3. Spain Chronic Obstructive Pulmonary Disease Product Sales Forecast
7.4. Spain Chronic Obstructive Pulmonary Disease Market Share Analysis
8. UK Chronic Obstructive Pulmonary Disease Market Insights
8.1. Marketed Products for Chronic Obstructive Pulmonary Disease in UK
8.2. UK Chronic Obstructive Pulmonary Disease Market Size & Forecast
8.3. UK Chronic Obstructive Pulmonary Disease Product Sales Forecast
8.4. UK Chronic Obstructive Pulmonary Disease Market Share Analysis
9. Europe Chronic Obstructive Pulmonary Disease Market Insights
9.1. Europe Chronic Obstructive Pulmonary Disease Market Size & Forecast
9.2. Europe Chronic Obstructive Pulmonary Disease Product Sales Forecast
9.3. Europe Chronic Obstructive Pulmonary Disease Market Share Analysis
10. Research Methodology
LIST OF TABLES
Table 1: Chronic Obstructive Pulmonary Disease Phase 3 Clinical Trials, Global, 2017
Table 2: Chronic Obstructive Pulmonary Disease Phase 2 Clinical Trials, Global, 2017
Table 3: Chronic Obstructive Pulmonary Disease Phase 1 Clinical Trials, Global, 2017
Table 4: Chronic Obstructive Pulmonary Disease Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Chronic Obstructive Pulmonary Disease in Germany, 2017
Table 6: Germany Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2012 - 2021
Table 8: Germany Chronic Obstructive Pulmonary Disease Market Trends, 2012 - 2021
Table 9: Marketed Products for Chronic Obstructive Pulmonary Disease in France, 2017
Table 10: France Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2012 - 2021
Table 12: France Chronic Obstructive Pulmonary Disease Market Trends, 2012 - 2021
Table 13: Marketed Products for Chronic Obstructive Pulmonary Disease in Italy, 2017
Table 14: Italy Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2012 - 2021
Table 16: Italy Chronic Obstructive Pulmonary Disease Market Trends, 2012 - 2021
Table 17: Marketed Products for Chronic Obstructive Pulmonary Disease in Spain, 2017
Table 18: Spain Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2012 - 2021
Table 20: Spain Chronic Obstructive Pulmonary Disease Market Trends, 2012 - 2021
Table 21: Marketed Products for Chronic Obstructive Pulmonary Disease in UK, 2017
Table 22: UK Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2012 - 2021
Table 24: UK Chronic Obstructive Pulmonary Disease Market Trends, 2012 - 2021
Table 25: Europe Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Chronic Obstructive Pulmonary Disease Pipeline by Phase (%), Global, 2017
Figure 2: Chronic Obstructive Pulmonary Disease Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Chronic Obstructive Pulmonary Disease Market Size ($mn), 2012 - 2021
Figure 4: Germany Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2012 - 2021
Figure 5: Germany Chronic Obstructive Pulmonary Disease Market Share by Products (%), 2016
Figure 6: Germany Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2021
Figure 7: France Chronic Obstructive Pulmonary Disease Market Size ($mn), 2012 - 2021
Figure 8: France Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2012 - 2021
Figure 9: France Chronic Obstructive Pulmonary Disease Market Share by Products (%), 2016
Figure 10: France Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2021
Figure 11: Italy Chronic Obstructive Pulmonary Disease Market Size ($mn), 2012 - 2021
Figure 12: Italy Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2012 - 2021
Figure 13: Italy Chronic Obstructive Pulmonary Disease Market Share by Products (%), 2016
Figure 14: Italy Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2021
Figure 15: Spain Chronic Obstructive Pulmonary Disease Market Size ($mn), 2012 - 2021
Figure 16: Spain Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2012 - 2021
Figure 17: Spain Chronic Obstructive Pulmonary Disease Market Share by Products (%), 2016
Figure 18: Spain Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2021
Figure 19: UK Chronic Obstructive Pulmonary Disease Market Size ($mn), 2012 - 2021
Figure 20: UK Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2012 - 2021
Figure 21: UK Chronic Obstructive Pulmonary Disease Market Share by Products (%), 2016
Figure 22: UK Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2021
Figure 23: Europe Chronic Obstructive Pulmonary Disease Market Size ($mn), 2012 - 2021
Figure 24: Europe Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2012 - 2021
Figure 25: Europe Chronic Obstructive Pulmonary Disease Market Share by Products (%), 2016
Figure 26: Europe Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report